Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8662510 | International Journal of Cardiology | 2018 | 4 Pages |
Abstract
If drug-induced type1 carries low arrhythmic risk, it should seldom be the only marker for BrS after an ACA. In studies on patients after an unexpected ACA, a drug-induced type1 leads to the diagnosis of BrS more often than anticipated. This contrasts with prospective studies focusing on patients already diagnosed as BrS and which consider drug-induced type1 as a marker of low risk. Contrary to current views, it is possible that not all patients with a drug-induced BrS type1 are at low risk of future events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pietro Delise, Giuseppe Allocca, Nadir Sitta, Federico Migliore, Federica Dagradi, Carla Spazzolini, Luigi Sciarra, Valeria Carinci, Domenico Corrado, Leonardo Calò, Peter J. Schwartz,